2023 International Headache Academy
PROGRAM GOALS
The International Headache Academy is designed to inspire a long-term commitment to headache medicine in young neurologists and research scientists via an educational program focused on clinical and research aspects of the field.
The American Headache Society is dedicated to mentoring future leaders in headache medicine through both outreach and continued education.
The Ninth IHA will be held January 20-22, 2023 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.
HEALTH AND SAFETY
The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event, which may include wearing personal protective gear, engaging in social distancing, agreeing to temperature checks or COVID-19 testing requirements, or providing proof of COVID-19 vaccination status. All attendees may have to produce proof of vaccination when you arrive at the meeting.
2023 International Headache Academy
IHA Planning and Research Committee Co-Chairs
Elizabeth Leroux, MD |
William Renthal, MD, PhD, FAHS |
2023 International Headache Academy
PURPOSE/OBJECTIVE
At the conclusion of the program, participants will be able to:
- Identify and describe the role of physiologic structures and systems involved in migraine, cluster headache, and related primary headache conditions
- Diagnose patients presenting with primary and secondary head pain based on data from history-taking, knowledge of diagnostic criteria, and findings from epidemiologic studies
- Develop evidence-based treatment plans involving medications/devices, complementary and alternative medicine, and/or behavioral techniques
- Effectively communicate with headache patients and caregivers, both in eliciting information for history taking and providing information for education
- Remember the steps involved in conducting a clinical trial and preparing the findings for publication
- Explain how Headache Medicine can be a rewarding career choice and a viable practice model and evaluate opportunities to enter or advance in the field
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Live activity for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS FOR CLAIMING CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
DISCLOSURE STATEMENT AND DISCLOSURES
The planners and faculty for this activity have no relevant relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERCIAL SUPPORT
The American Headache Society gratefully acknowledges the educational grants received for the International Headache Academy from our Industry Supporters:
AbbVie Inc.
Lilly USA, LLC
2023 International Headache Academy
2023 International Headache Academy Program Agenda*
*Subject to change
| Friday, January 20, 2023 | |
| 6:00 pm – 7:30 pm | Faculty and Delegate Reception |
| Saturday, January 21, 2023 | |
| 7:00 am – 8:00 am | Continental Breakfast |
| 8:00 am – 8:05 am | Welcome and Introduction
Speaker: William Renthal, MD, PhD, FAHS |
| 8:05 am – 8:10 am | AHS Presidential Welcome
Speaker: Andrew C. Charles, MD, FAHS |
| 8:10 am – 8:40 am
|
Keynote Presentation: MABs and Gepants: New Questions, New Answers
Speaker: Jessica Ailani, MD, FAHS |
| 8:40 am – 8:50 am | Question and Answer |
| 8:50 am – 9:30 am
|
Statement for Debate: Neuromodulation for Primary Headache: Are Clinical Results Worth the Cost and Effort
Moderator: Stewart J. Tepper, MD, FAHS
8:50 am – 9:05 am (Pro) Delegate: Kendra Pham, MD, MPH
9:05 am – 9:20 am (Con) Delegate: Crystal Jicha, MD
9:20 am – 9:30 am Question and Answer
|
| 9:30 am – 10:00 am
|
Funding Headache Research
9:30 am – 9:45 am Additional Funding Opportunities Speaker: Richard Lipton, MD, FAHS |
| 9:45 am –10:00 am | Question and Answer |
| 10:00 am – 10:20 am | Special Session: Top Questions the Field Needs to Answer
Speaker: Peter J. Goadsby, MD, PhD, FAHS
|
| 10:20 am – 10:30 am | Question and Answer |
| 10:30 am – 10:50 am | Refreshment Break |
| 10:50 am – 11:20 am | Translation of Headache Models into Practice
Speaker: Andrew C. Charles, MD, FAHS
|
| 11:20 am – 11:30 am | Question and Answer |
| 11:30 am -12:00 pm | Clinical Case Presentations: Session 1
Moderator: Amy Gelfand, MD, MAS, FAHS
11:30 am -11:40 am Red Ear Syndrome Delegate: Daniel Noam Lax, MD
11:40 am – 11:45 am Question & Answer
11:45 am – 11:55 am Paroxysmal Hemicrania in Children Delegate: Rachel Evans, MD
11:55 am – 12:00 pm Question & Answer
|
| 12:00 pm – 1:00 pm | Lunch and Group Photo |
| 1:00 pm – 1:40 pm | Keynote Presentation: How and When to Image Headache Patients
Speaker: David Dodick, MD, FAHS |
| 1:40 pm – 1:50 pm | Question and Answer |
| 1:50 pm – 2:25 pm
|
Best Research Basic Science 2022
Moderator: Amynah Pradhan, PhD
1:50 pm – 2:00 pm The impact of obesity-related raised intracranial pressure in rodents Delegate: Atlantic D’Souza, MBBS, MRCP
2:00 pm – 2:10 pm Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice Delegate: Vimala Bharadwaj, PhD
2:10 pm – 2:20 pm MNK1/2 contributes to periorbital hypersensitivity and hyperalgesic priming in preclinical migraine models Delegate: Jhoan Aguilar, BS
2:20 pm – 2:25 pm Question and Answer |
| 2:25 pm – 2:40 pm | Refreshment Break |
| 2:40 pm – 3:30 pm
|
Special Session: Refractory Patients
2:40 pm – 3:00 pm Behavioral Approaches: Tricks from the Field Speaker: Elizabeth Leroux, MD, FRCPC
3:00 pm – 3:20 pm Pharmacological 3,4th… 10th Line Speaker: Stephanie Nahas, MD, MSEd, FAHS
3:20 pm – 3:30 pm Question and Answer |
| 3:30 pm – 4:00 pm | Clinical Case Presentations: Session 2
Moderator: Elizabeth Leroux, MD, FRCPC
3:30 pm – 3:40 pm Migraine Management in Pregnancy Delegate: Santosh Bhaskarabhatla, MD
3:40 pm – 3:45 pm Question and Answer
3:45 pm – 3:55 pm Unmasking CHARGE Syndrome Delegate: Arthur Washington, MD
3:55 pm – 4:00 pm Question and Answer
|
| 4:00 pm – 4:10 pm | Conclusion |
| 6:00 pm – 8:30 pm | Faculty and Delegate Dinner |
| Sunday, January 22, 2023 | |
| 7:00 am – 7:50 am | Continental Breakfast |
| 7:50 am – 7:55 am | Introduction and Welcome Back
Elizabeth Leroux, MD, FRCPC |
| 7:55 am – 8:05 am | Funding Headache Research
7:55 am – 8:05 am NIH Speaker: Michael Oshinsky, PhD
|
| 8:05 am – 8:10 am | Question and Answer |
| 8:10 am – 9:00 am
|
Research Presentations: Results
Moderator: Robert E. Shapiro, MD, PhD, FAHS
8:10 am – 8:25 am Acute and Persistent Post-Traumatic Headache-Related Pain in a rodent model: Effect of voluntary exercise Delegate: Vimala Bharadwaj, PhD
8:25 am – 8:35 am Question and Answer
8:35 am – 8:50 am Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged ≥65 years with episodic or chronic migraine Delegate: Sudipa Biswas, MD
8:50 am – 9:00 am Question and Answer |
| 9:00 am – 9:20 am | Advocacy and Headache Medicine
Speaker: Robert E. Shapiro, MD, PhD, FAHS |
| 9:20 am – 9:30 am | Question and Answer |
| 9:30 am – 10:10 am
|
Research Presentations: Proposals
Moderator: William Renthal, MD, PhD, FAHS
9:30 am – 9:45 am Contribution of intraganglionar S1P-S1PR1 axis to peripheral and central sensitization in a migraine-like model. Delegate: Ana Salinas-Abarca, PhD
9:45 am -9:50 am Question and Answer
9:50 am – 10:05 am Macromastia and Headache: Defining the Headache Prior to Reduction Mammoplasty Delegate: Kristyn Pocock, MD
10:05 am – 10:10 am Question and Answer
|
| 10:10 am – 10:30 am | Refreshment Break |
| 10:30 am – 11:15 am | Clinical Case Presentations: Session 3
Moderator: Amaal Starling, MD, MS, FAHS
10:30 am – 10:40 am Mollaret’s Meningitis Delegate: Molly Fensterwald, MD
10:40 am – 10:45 am Question and Answer
10:45 am – 10:55 am HaNDL Delegate: Sina Marzoughi, MD
10:55 am – 11:00 am Question and Answer
11:00 am – 11:10 am Glossopharyngeal Neuralgia Delegate: Maksym Marek, MD, MS
11:10 am -11:15 am Question and Answer
|
| 11:15 am – 11:50 am
|
Best Research Clinical 2022
Moderator: Andrew Charles, MD, FAHS
11:15 am – 11:25 am Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial Delegate: Aakash Bhargava, MD
11:25 am – 11:35 am Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial Delegate: Ankur Banerjee, MD on behalf of Caitlin Christensen, MD
11:35 am – 11:45 am Psychological disorders, adverse childhood experiences and parental psychiatric disorders in children affected by headache: A systematic review Delegate: Hannah Shapiro, MD
11:45 am – 11:50 am Question and Answer
|
| 11:50 am – 12:00 pm | Conclusion
William Renthal, MD, PhD, FAHS and Elizabeth Leroux, MD, FRCPC
|
2023 International Headache Academy
Candidate Criteria
Interested applicants must be a PGY 3+ Resident, headache medicine fellow, or MD and/or PhD clinician/researcher currently enrolled or within 5 years of having completed their training in the US, Canada, or Latin America. Previous participants of IHA are encouraged to apply should you meet eligibility requirements as outlined.
Application and Supporting Materials
Applicants must complete an online application form and provide the following supporting materials:
- CV
- Brief academic update (presentations delivered, abstracts published, manuscripts published or in press, book chapters published or in press, academic promotion, academic appointments, projects funded, or any other update)
- Letter of support from Department Chair, Program Director, or AHS member
- A demonstrated interest in headache medicine
- Completion of statement of interest and financial disclosure form
Applications will be reviewed and rated according to the following:
- Academic history and productivity
- Field of study
- Place of study
- Quality of research to date (if any)
- Potential for the applicant to provide leadership in headache medicine and make meaningful contributions to headache research and/or clinical care for many years
Accepted applicants will receive:
Through submission of an optional research proposal, selected applicants may be eligible to receive a $10,000 grant to fund their research project, and those selected will be invited to present at the 66th Annual Scientific Meeting in 2024.
Accepted applicants will also receive a stipend up to $1,500 toward eligible travel expenses and a one-year AHS Trainee membership or a extension of their existing Trainee membership.
Thank you for your interest in the 2023 International Headache Academy. The application period has passed and final recipients will be notified of acceptance on or about Monday, October 17, 2022.
2023 International Headache Academy
AHS gratefully acknowledges the educational grant support of the 2023 International Headache Academy from our industry supporters:
AbbVie Inc.
Lilly USA, LLC